@xconomy.com 8 months ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com 11 months ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com 1 year ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments